Your browser doesn't support javascript.
loading
Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report.
Watanabe, Masayuki; Matsumura, Yuki; Yamaguchi, Hikaru; Mine, Hayato; Takagi, Hironori; Ozaki, Yuki; Fukuhara, Mitsuro; Muto, Satoshi; Okabe, Naoyuki; Shio, Yutaka; Suzuki, Hiroyuki.
Afiliación
  • Watanabe M; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
  • Matsumura Y; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
  • Yamaguchi H; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
  • Mine H; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
  • Takagi H; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
  • Ozaki Y; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
  • Fukuhara M; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
  • Muto S; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
  • Okabe N; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
  • Shio Y; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
  • Suzuki H; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
Thorac Cancer ; 13(19): 2817-2822, 2022 10.
Article en En | MEDLINE | ID: mdl-36064196

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Neuroendocrino / Carcinoma de Células Grandes / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Aged / Humans / Male Idioma: En Revista: Thorac Cancer Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Neuroendocrino / Carcinoma de Células Grandes / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Aged / Humans / Male Idioma: En Revista: Thorac Cancer Año: 2022 Tipo del documento: Article País de afiliación: Japón